Chemical Structure (Viracept 01)
Viracept Tablet, Film Coated
Product Images NDC 63010-027
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Viracept (NDC 63010-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Agouron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Viracept 02)
Principal Display Panel (250 mg Tablet Bottle Label)
This is the description of VIRACEPT medication, a drug used for the treatment of HIV. Each tablet contains nelfinavir mesylate equivalent to 1250mg nelfinavir. The medication comes in 300 tablets and is manufactured by Roche Pharmaceuticals, LLC. The text also contains a note to pharmacists to not cover the ALERT box with a pharmacy label, and mentions that there are some medicines that should not be taken with VIRACEPT. The text indicates that the product was made in Japan.*
Principal Display Panel (625 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
